We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

53 hedge funds and large institutions have $122M invested in Fibrocell Science Inc. in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 5553 (-2)

16% less capital invested

Capital invested by funds: $145M → $122M (-$22.7M)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

49% less call options, than puts

Call options by funds: $18K | Put options by funds: $35K

Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
26
Reduced
14
Closed
7
Calls
$18K
Puts
$35K
Net Calls
-$17K
Net Calls Change
-$85K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$188K +$46.8K +529 +19%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$183K +$15.9K +180 +6%
Morgan Stanley
28
Morgan Stanley
New York
$163K +$210K +2,376 +525%
SIM
29
Spark Investment Management
New York
$159K +$169K +1,914 +224%
TA
30
Teachers Advisors
New York
$139K
Goldman Sachs
31
Goldman Sachs
New York
$135K -$94.6K -1,069 -31%
Charles Schwab
32
Charles Schwab
California
$135K
CCM
33
Context Capital Management
California
$119K -$10.6K -120 -5%
BIP
34
Brandes Investment Partners
California
$87K
VKH
35
Virtu KCG Holdings
New York
$86K +$6.99K +79 +6%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$82K +$5.13K +58 +4%
EEG
37
E.E. Geduld
$77K -$117K -1,327 -50%
NFA
38
Nationwide Fund Advisors
Ohio
$67K +$10.5K +119 +11%
BA
39
BlackRock Advisors
Delaware
$64K +$8.67K +98 +10%
AIG
40
American International Group
New York
$55K +$89 +1 +0.1%
SO
41
STRS Ohio
Ohio
$51K
Creative Planning
42
Creative Planning
Kansas
$35K +$53.1K +600 New
Deutsche Bank
43
Deutsche Bank
Germany
$27K +$7.7K +87 +22%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$20.8K +$19.8K +224 +165%
Wells Fargo
45
Wells Fargo
California
$5K -$620 -7 -8%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$4K -$2.39K -27 -28%
S
47
SignatureFD
Georgia
$4K
TWA
48
TCI Wealth Advisors
Arizona
$3K -$1.15K -13 -22%
UBS Group
49
UBS Group
Switzerland
$2K -$12.5K -141 -81%
KF
50
Krilogy Financial
Missouri
$2K +$2.92K +33 New

FCSC Hedge Fund Activity: Q3 2015 in Review

53 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2015, worth a combined $122M — down 16% from $145M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of FCSC and 5 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 26 added.

The largest buyer was QVT Financial, opening a new position worth an estimated $11M. The largest seller was Belmont Global Advisors, exiting entirely with an estimated $509K sold.

  • 53 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2015, down from 55 in Q2 2015.
  • Funds reported $122M of Fibrocell Science Inc. stock for Q3 2015, down 16% quarter-over-quarter.
  • 5 funds opened new Fibrocell Science Inc. positions in Q3 2015 and 7 closed out, a net change of -2 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2015 was QVT Financial, an estimated $11M added.
  • The largest Fibrocell Science Inc. seller in Q3 2015 was Belmont Global Advisors, an estimated $509K sold.

Based on aggregated 13F filings for Q3 2015.